Business Context and Reporting Period
Company: Phibro Animal Health Corporation (PAHC)
Filing Type: Form 8-K (Current Report)
Report Date: May 6, 2026
Reporting Period: Fiscal quarter ended March 31, 2026
This filing serves as a notification that the company issued a press release on May 6, 2026, announcing operating results for the first quarter of fiscal year 2026 and providing financial guidance for the full fiscal year ending June 30, 2026.
Key Financial Metrics
The provided text is a cover page and index for the Form 8-K. It references a press release (Exhibit 99.1) containing the specific financial data but does not include the numerical values within this document.
- Revenue, Profit, Cash Flow, Margins: Not provided in this text; contained in the referenced press release.
- Debt and Liquidity: Not provided in this text; contained in the referenced press release.
Material Changes
The filing text does not provide specific details regarding material changes versus the prior comparable period. It only confirms that results for the quarter ended March 31, 2026, were announced.
Guidance, Outlook, and Management Commentary
Guidance: The company issued financial guidance for the fiscal year ending June 30, 2026, as part of the May 6, 2026 press release.
Management Commentary: Specific commentary is not included in this filing text; it is located in the attached press release (Exhibit 99.1).
Risks and Contingencies: No specific risks or contingencies are detailed in this cover document.
Important Facts for Investor Verification
- Verify the specific revenue and earnings figures for the quarter ended March 31, 2026, by reviewing Exhibit 99.1 (Press Release).
- Review the full-year 2026 financial guidance provided in the press release to assess management's outlook.
- Note that the information in this 8-K is furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act, nor incorporated by reference into other filings unless expressly stated.